| PATHWAY_NAME |
REACTOME_ID |
KEGG_ID |
DRUG_NAME |
PUBCHEM_CID |
Datasource |
| Telithromycin Action Pathway |
R-HSA-9639775 |
0 |
(1R,2S,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone |
94141 |
pubchem |
| Metabolism |
R-HSA-1430728 |
0 |
MeCbl |
71306319 |
pubchem |
| Metabolism of vitamins and cofactors |
R-HSA-196854 |
0 |
MeCbl |
71306319 |
pubchem |
| Metabolism of water-soluble vitamins and cofactors |
0 |
0 |
MeCbl |
71306319 |
pubchem |
| Cobalamin transport and metabolism |
R-HSA-9759218 |
0 |
MeCbl |
71306319 |
pubchem |
| Amino acid and derivative metabolism |
R-HSA-1614635 |
0 |
MeCbl |
71306319 |
pubchem |
| Sulfur amino acid metabolism |
R-HSA-1614635 |
0 |
MeCbl |
71306319 |
pubchem |
| Biological oxidations |
R-HSA-211859 |
0 |
MeCbl |
71306319 |
pubchem |
| Phase II - Conjugation of compounds |
R-HSA-156580 |
0 |
MeCbl |
71306319 |
pubchem |
| Methylation |
R-HSA-156581 |
0 |
MeCbl |
71306319 |
pubchem |
| Disease |
R-HSA-1643685 |
0 |
MeCbl |
71306319 |
pubchem |
| Diseases of metabolism |
R-HSA-5668914 |
0 |
MeCbl |
71306319 |
pubchem |
| Defects in vitamin and cofactor metabolism |
R-HSA-3296482 |
0 |
MeCbl |
71306319 |
pubchem |
| Defects in cobalamin metabolism |
R-HSA-3296469 |
0 |
MeCbl |
71306319 |
pubchem |
| Defective MTR causes HMAG |
R-HSA-3359469 |
0 |
MeCbl |
71306319 |
pubchem |
| Vitamin B12 metabolism |
R-HSA-6806664 |
0 |
MeCbl |
71306319 |
pubchem |
| One-carbon metabolism |
R-HSA-1430728 |
0 |
MeCbl |
71306319 |
pubchem |
| Vitamin B12 disorders |
R-HSA-8877627 |
0 |
MeCbl |
71306319 |
pubchem |
| Methionine metabolism leading to sulfur amino acids and related disorders |
0 |
0 |
MeCbl |
71306319 |
pubchem |
| Cobalamin metabolism |
R-HSA-9759218 |
0 |
MeCbl |
71306319 |
pubchem |